Citi analyst Patrick Donnelly added an “upside 90-day catalyst watch” on shares of Thermo Fisher (TMO) while keeping a Buy rating on the name with a $685 price target ahead of the Q1 report. Citi believes the stock’s recent selloff does not reflect its guidance and the recent Clario acquisition.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target lowered, added to ‘Tactical Outperform’ at Evercore
- Citi, Meta among ‘Top 10 US Ideas for Q2’ at BofA
- Thermo Fisher initiated with a Buy at DZ Bank
- Thermo Fisher Scientific: Early Clario Close Enhances 2026 Growth Outlook and AI-Driven Competitive Position, Supporting Buy Rating
- Thermo Fisher Completes Strategic Acquisition of Clario Holdings